Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-07-02 | New | $925,000 | $925,000 | Equity Only | 06b | SEC link |
2025-04-15 | New | $750,000 | $750,000 | Equity Only | 06b | SEC link |
2024-08-21 | New | $500,000 | $500,000 | Equity Only | 06b | SEC link |
2024-08-21 | New | $500,000 | $500,000 | Equity Only | 06b | SEC link |
2023-10-11 | New | $2,884,615 | $2,884,615 | Debt Only | 06b | SEC link |
2023-03-06 | New | $1,384,616 | $1,384,616 | Debt Only | 06b | SEC link |
2023-02-03 | New | $2,307,693 | $2,307,693 | Equity and Debt | 06b | SEC link |
2020-10-16 | New | $25,000,000 | $25,000,000 | Debt Only | 06b | SEC link |
2020-05-06 | New | $15,000,000 | $15,000,000 | Debt Only | 06b | SEC link |
2019-04-22 | New | $30,000,001 | $30,000,001 | Equity Only | 06b | SEC link |
2019-02-14 | New | $6,300,000 | $6,300,000 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
Russell Barrans | Executive |
Kelly Cullwell | Executive |
Kelly Culwell | Executive |
Justin File | Executive |
Alexander A. Fitzpatrick | Executive |
Gillian Greer | Director |
William Hall | Director |
Kim Kamdar | Director |
Thomas Lynch | Director |
Tony O'brian | Director |
Tony O'brien | Director |
Saundra Pelletier | Director, Executive |
Lisa Rarick | Director |
Colin Rutherford | Director |
Jenny Yip | Director |
Ivy Zhang | Executive |